• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

慢性肾脏病一种较罕见病因的识别与管理：常染色体显性多囊肾病

Recognition and Management of a Less Common Cause of Chronic Kidney Disease: Autosomal Dominant Polycystic Kidney Disease.

作者信息

Weir Matthew

机构信息

Division of Nephrology, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.

出版信息

J Fam Pract. 2020 Sep;69(7 Suppl):S57-S62.

PMID:33104109
Abstract

After reading this review article on ADPKD, participants should be able to: Identify people at high risk for ADPKD. Conduct a diagnostic evaluation. Initiate evidence-based therapy to slow kidney progression and treat extra-renal manifestations.

摘要

阅读这篇关于常染色体显性多囊肾病（ADPKD）的综述文章后，参与者应能够：识别ADPKD的高危人群。进行诊断评估。启动循证治疗以减缓肾脏病变进展并治疗肾外表现。

相似文献

1
Recognition and Management of a Less Common Cause of Chronic Kidney Disease: Autosomal Dominant Polycystic Kidney Disease.慢性肾脏病一种较罕见病因的识别与管理：常染色体显性多囊肾病
J Fam Pract. 2020 Sep;69(7 Suppl):S57-S62.
2
Extra-renal manifestations of autosomal dominant polycystic kidney disease (ADPKD): considerations for routine screening and management.常染色体显性多囊肾病（ADPKD）的肾外表现：常规筛查与管理的考量
Nephrol Dial Transplant. 2014 Feb;29(2):247-54. doi: 10.1093/ndt/gft437. Epub 2013 Nov 8.
3
Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.常染色体显性多囊肾病（ADPKD）：来自改善全球肾脏病预后组织（KDIGO）争议会议的执行摘要
Kidney Int. 2015 Jul;88(1):17-27. doi: 10.1038/ki.2015.59. Epub 2015 Mar 18.
4
Analysis of data from the ERA-EDTA Registry indicates that conventional treatments for chronic kidney disease do not reduce the need for renal replacement therapy in autosomal dominant polycystic kidney disease.来自 ERA-EDTA 注册处的数据分析表明，针对常染色体显性遗传性多囊肾病的常规治疗并不能减少肾脏替代疗法的需求。
Kidney Int. 2014 Dec;86(6):1244-52. doi: 10.1038/ki.2014.120. Epub 2014 May 14.
5
Autosomal dominant polycystic kidney disease: pathophysiology and treatment.常染色体显性多囊肾病：病理生理学与治疗
ANNA J. 1997 Feb;24(1):45-51; quiz 52-3.
6
Autosomal dominant polycystic kidney disease: Study of clinical characteristics in an Indian population.常染色体显性多囊肾病：印度人群临床特征研究
Saudi J Kidney Dis Transpl. 2017 Jan-Feb;28(1):115-124. doi: 10.4103/1319-2442.198163.
7
Rationale and study protocol of ACQUIRE, a prospective, observational study measuring quality of life, treatment preference and treatment satisfaction of autosomal dominant polycystic kidney disease (ADPKD) patients in Europe.ACQUIRE 研究的原理和方案：一项在欧洲开展的前瞻性、观察性研究，旨在评估常染色体显性遗传性多囊肾病（ADPKD）患者的生活质量、治疗偏好和治疗满意度。
BMC Nephrol. 2020 Jul 24;21(1):298. doi: 10.1186/s12882-020-01927-1.
8
Spanish guidelines for the management of autosomal dominant polycystic kidney disease.常染色体显性多囊肾病管理的西班牙指南。
Nephrol Dial Transplant. 2014 Sep;29 Suppl 4:iv95-105. doi: 10.1093/ndt/gfu186.
9
Autosomal dominant polycystic kidney disease.常染色体显性多囊肾病。
Am Fam Physician. 2014 Sep 1;90(5):303-7.
10
Autosomal dominant polycystic kidney disease: a case study.常染色体显性多囊肾病：病例研究
Nephrol Nurs J. 2009 Jan-Feb;36(1):41-7.

引用本文的文献

1
Mental Health and Autosomal Dominant Polycystic Kidney Disease: A Narrative Review.精神健康与常染色体显性遗传性多囊肾病：叙述性综述。
Kidney360. 2024 Aug 1;5(8):1200-1206. doi: 10.34067/KID.0000000000000504. Epub 2024 Jul 8.